CHARLOTTESVILLE, Va.--(BUSINESS WIRE)--Xdynia LLC, a preclinical pharmaceutical company developing drugs for the treatment of neuropathic pain, announced today that President Yuri Maricich, MD, MBA, is to speak at the 2012 Mid-Atlantic Bio Conference in Bethesda, Maryland, September 27-28, 2012. Dr. Maricich will present Xdynia’s innovative business and therapeutic strategies to an audience of more than 850 people, including investors, scientists and advisors from the life sciences sector.
